Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.4445
-0.0011 (-0.25%)
At close: Nov 11, 2026, 4:00 PM EST
0.4599
+0.0154 (3.46%)
Pre-market: Nov 12, 2026, 8:14 AM EST
APRE's stock price has decreased by -65% in the past year and price targets may not have had time to catch up.
Aprea Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $5 | Buy | Maintains | $5 | +1,024.86% | Nov 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $1.2 | Buy | Maintains | $1.2 | +169.97% | Nov 5, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Initiates $2 | Buy | Initiates | $2 | +349.94% | Oct 14, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $5 | Buy | Reiterates | $5 | +1,024.86% | Aug 13, 2026 |
| Wedbush | Wedbush | Buy Reiterates $7 → $6 | Buy | Reiterates | $7 → $6 | +1,249.83% | May 14, 2026 |